AHR and breast cancer: Given these prior reports, the purpose of this study was to examine the possibility that specific ligand-activated AHR inhibits mitogenic adipokine signaling in human MCF-7 breast cancer cells and to provide preliminary insights into the mechanism by which this occurs.